巴西医护人员百日咳抗体与疫苗接种覆盖率不足:一项横断面血清学研究
该研究在2020年对巴西圣保罗医院352名医护人员进行横断面血清学调查,发现331/352人不知晓巴西国家免疫规划推荐医护人员接种Tdap,68/339人接种过Tdap,55/352人抗百日咳毒素IgG血清学阴性且均未接种疫苗,接种者抗PT IgG>50 IU/mL的概率是未接种者的11.5倍(p<0.001)。
要点
- 331/352名医护人员不知晓巴西国家免疫规划推荐所有医护人员和孕妇接种Tdap。
- 55/352名医护人员抗PT IgG血清学阴性,且均未接种Tdap疫苗。
- 接种Tdap者抗PT IgG>50 IU/mL的概率是未接种者的11.5倍(p<0.001)。
核心结论
- 亟需加强对医护人员进行Tdap疫苗接种必要性和益处的教育,目标是提高医护人员的疫苗接种覆盖率。
研究设计与样本
- 观察性横断面血清学研究,纳入2020年在巴西圣保罗医院-联邦圣保罗大学(UNIFESP)工作的352名医护人员,经UNIFESP伦理委员会批准。
主要发现
- 331/352名医护人员不知晓巴西国家免疫规划推荐所有医护人员和孕妇接种Tdap。
- 68/339名医护人员接种过Tdap,平均接种时间3.1±2.0年。
- 55/352名医护人员抗PT IgG血清学阴性,均未接种疫苗;56/271名无Tdap接种史者呈高阳性。
- 接种Tdap者抗PT IgG>50 IU/mL的概率是未接种者的11.5倍(p<0.001)。
- 抗PT IgG与Tdap接种间隔呈弱但显著相关(r=0.404;p=0.001);抗PT IgG每年下降5 IU/mL(p=0.001)。
关键数值与推荐
- 抗PT IgG ELISA结果判读:<10 IU/mL为血清学阴性;≥10-1000 IU/mL为血清学阳性;≥10-50 IU/mL为低阳性,提示无近期百日咳杆菌感染或Tdap接种;>50 IU/mL为高阳性,提示近期百日咳杆菌感染或Tdap接种;>100 IU/mL为急性百日咳杆菌感染或过去一年内Tdap接种。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Worldwide, tetanus-diphtheria-acellular pertussis (Tdap) vaccination coverage of healthcare professionals (HCPs) is below 40%, but this data is not available for Brazil. We hypothesize that a high number of HCPs are not immune to pertussis in Brazil. Main objective was to determine the seroprevalence of anti-pertussis toxin (anti-PT IgG) among HCPs. Secondary objectives were to evaluate Tdap vaccination coverage, to assess predictive factors associated with anti-PT IgG, and to estimate the decay of anti-PT IgG and time to Tdap vaccination. METHODS: Observational cross-sectional serological study in 352 HCPs who worked at São Paulo Hospital - Federal University of São Paulo (UNIFESP) in 2020, approved by UNIFESP Ethics Committee. Data collected included sociodemographics, knowledge about Tdap, and vaccination status. Anti-PT IgG were quantified by ELISA: <10 IU/mL seronegative and ≥ 10-1000 IU/mL seropositive. Titers ≥ 10-50 IU/mL were classified low positivity, indicating no recent B. pertussis infection or Tdap vaccination; >50 IU/mL high positivity, indicating recent B. pertussis infection or Tdap vaccination, and > 100 IU/mL as acute B. pertussis infection or Tdap vaccination in the previous year. Comparisons were done by Chi-square test, multivariable logistic regression, and Pearsońs correlation, at 5% p-level. RESULTS: 331/352 HCPs were not aware the Brazilian National Immunization Program recommends Tdap for all HCPs and pregnant women. 68/339 HCPs received Tdap (mean 3.1 ± 2.0 years). 55/352 were seronegative for pertussis, all unvaccinated. 56/271 with no history of Tdap vaccination had high positivity. The probability of anti-PT IgG > 50 IU/mL was 11.5 times higher in Tdap vaccinated HCPs than in non-vaccinated (p < 0.001). There was a weak but significant correlation between anti-PT IgG and interval of Tdap vaccination (r = 0.404; p = 0.001). Anti-PT IgG dropped 5 IU/mL/year (p = 0.001). CONCLUSION: Better education of HCPs on needs and benefits of Tdap vaccination is critical. Goals must be to improve HCPs vaccination coverage.
引用
- Cardona RSB, Weckx LY, de Moraes-Pinto MI, et al. Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: A cross-sectional serological study. Vaccine. 2023. PMID: 37573201. doi:10.1016/j.vaccine.2023.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。